| 摘要 |
PROBLEM TO BE SOLVED: To provide an isotonic alendronate composition for intravenous infusion and for treating metabolic bone diseases of human patient, such as metastatic bone disease, malignant hypercalcemia and/or osteoporosis. SOLUTION: A therapeutic protocol for treating a patient having metastatic bone disease, malignant hypercalcemia and/or osteoporosis by administrating a composition isotonic with human blood and for a citric buffer alendronate intravenous infusion is provided. COPYRIGHT: (C)2004,JPO
|
